Durata Therapeutics, Inc. To Present At Upcoming Investor Conference
CHICAGO, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Durata Therapeutics (Nasdaq:DRTX) announced today that Paul R. Edick, Chief Executive Officer, will present at the Wedbush 2014 Life Sciences Management Access Conference on August 13, 2014 at 9:45am EDT in New York, New York.
ABOUT DURATA THERAPEUTICS, INC.
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of new therapeutics for patients with infectious diseases and acute illnesses. For more information about the company, visit www.duratatx.com.
FORWARD-LOOKING STATEMENTS
Statements contained in this press release contain forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this press release, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
CONTACT: Allison Wey Vice President, Investor Relations and Public Affairs Durata Therapeutics (312) 219-7017 awey@duratatx.com 